Monday, July 6, 2020
Bottle of Lies: The Inside Story of the Generic Drug Boom by Katherine Eban
A scathing expose of the generic drugs industry, Eban’s reporting, especially in notoriously difficult-to-access India is commendable. The revelations will make you hesitate to ever settle for generics again. My small quibble with the narrative is that too much of it is trained on the misdeeds of one Indian company and too little on lax American oversight. It takes two to tango. Sure shocking manufacturing practices are to blame. But so is our bloated healthcare system which forces us into relying on sketchy outsourcing in the first place. A damning indictment of the lax oversight of the American pharma industry.